New #JITC short report: Tumor location as a risk factor for severe immune-related adverse events https://t.co/TIYsqShVcQ @sm_blum@kreynoldsMD@villanilab
We’re excited to see our paper published in @Nature!
Congrats to a fantastic team in the @villanilab and the @MGHCancerCenter!
I’d like to especially thank the patients and their families for participating in our effort. We are all tremendously grateful for their generosity.
🎉 CONGRATULATIONS TEAM 🎉
👏 Incredible effort by our brilliant team - special kudos to @sm_blum, @DZlotoff, #Neal, #Isabela, and #Swetha.
🔗 Go check out the fantastic tweetorial they have prepared to break down the key findings of our new study:
👋Hello, hola, bonjour, হ্যালো, xin chào, שלום, ciao, kumusta, witam! 👋
🐦Villani Lab is finally on Twitter!
🎉 We're thrilled to join this community and share our work.
🧵 Stay tuned to learn more about who we are and what we do! #VillaniLab#Immunology#CancerResearch
Attending the @ASCO annual meeting 11 years ago was one of the experiences that encouraged me towards the path of becoming a med-onc and physician scientist. I’m grateful for the chance to present our team’s work! @DZlotoff@villanilab@kreynoldsMD@TomasNeilan @MGHCancerCenter
FAP #colorectalcancer develops via CIN and #LynchSyndrome crcs develop via #MSI. So I always thought that FAP-related colorectal cancers would never be MSI-H. Until this case: https://t.co/7wy9DAYiuw Thanks to the pt for letting us publish her story @JNCCN@sm_blum